Table of Contents Chapter 1 Overview of Lupus Therapeutic 1.1 Definition of Lupus Therapeutic in This Report 1.2 Commercial Types of Lupus Therapeutic 1.2.1 Anti-inflammatory Drugs 1.2.2 Corticosteroids 1.2.3 Immunosuppressant Drugs 1.2.4 Antimalarial Drugs 1.2.5 Others 1.3 Downstream Application of Lupus Therapeutic 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Development History of Lupus Therapeutic 1.5 Market Status and Trend of Lupus Therapeutic 2013-2023 1.5.1 United States Lupus Therapeutic Market Status and Trend 2013-2023 1.5.2 Regional Lupus Therapeutic Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Lupus Therapeutic in United States 2013-2017 2.2 Consumption Market of Lupus Therapeutic in United States by Regions 2.2.1 Consumption Volume of Lupus Therapeutic in United States by Regions 2.2.2 Revenue of Lupus Therapeutic in United States by Regions 2.3 Market Analysis of Lupus Therapeutic in United States by Regions 2.3.1 Market Analysis of Lupus Therapeutic in New England 2013-2017 2.3.2 Market Analysis of Lupus Therapeutic in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Lupus Therapeutic in The Midwest 2013-2017 2.3.4 Market Analysis of Lupus Therapeutic in The West 2013-2017 2.3.5 Market Analysis of Lupus Therapeutic in The South 2013-2017 2.3.6 Market Analysis of Lupus Therapeutic in Southwest 2013-2017 2.4 Market Development Forecast of Lupus Therapeutic in United States 2018-2023 2.4.1 Market Development Forecast of Lupus Therapeutic in United States 2018-2023 2.4.2 Market Development Forecast of Lupus Therapeutic by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Lupus Therapeutic in United States by Types 3.1.2 Revenue of Lupus Therapeutic in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Lupus Therapeutic in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Lupus Therapeutic in United States by Downstream Industry 4.2 Demand Volume of Lupus Therapeutic by Downstream Industry in Major Countries 4.2.1 Demand Volume of Lupus Therapeutic by Downstream Industry in New England 4.2.2 Demand Volume of Lupus Therapeutic by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Lupus Therapeutic by Downstream Industry in The Midwest 4.2.4 Demand Volume of Lupus Therapeutic by Downstream Industry in The West 4.2.5 Demand Volume of Lupus Therapeutic by Downstream Industry in The South 4.2.6 Demand Volume of Lupus Therapeutic by Downstream Industry in Southwest 4.3 Market Forecast of Lupus Therapeutic in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Lupus Therapeutic 5.1 United States Economy Situation and Trend Overview 5.2 Lupus Therapeutic Downstream Industry Situation and Trend Overview Chapter 6 Lupus Therapeutic Market Competition Status by Major Players in United States 6.1 Sales Volume of Lupus Therapeutic in United States by Major Players 6.2 Revenue of Lupus Therapeutic in United States by Major Players 6.3 Basic Information of Lupus Therapeutic by Major Players 6.3.1 Headquarters Location and Established Time of Lupus Therapeutic Major Players 6.3.2 Employees and Revenue Level of Lupus Therapeutic Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Lupus Therapeutic Major Manufacturers Introduction and Market Data 7.1 F.Hoffmann-La Roche 7.1.1 Company profile 7.1.2 Representative Lupus Therapeutic Product 7.1.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche 7.2 GlaxoSmithKline 7.2.1 Company profile 7.2.2 Representative Lupus Therapeutic Product 7.2.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 7.3 Medlmmune 7.3.1 Company profile 7.3.2 Representative Lupus Therapeutic Product 7.3.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Medlmmune 7.4 Pfizer 7.4.1 Company profile 7.4.2 Representative Lupus Therapeutic Product 7.4.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Pfizer 7.5 ADMA Biologics 7.5.1 Company profile 7.5.2 Representative Lupus Therapeutic Product 7.5.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of ADMA Biologics 7.6 Amgen 7.6.1 Company profile 7.6.2 Representative Lupus Therapeutic Product 7.6.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Amgen 7.7 Anthera Pharmaceuticals 7.7.1 Company profile 7.7.2 Representative Lupus Therapeutic Product 7.7.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Anthera Pharmaceuticals 7.8 Bayer HealthCare 7.8.1 Company profile 7.8.2 Representative Lupus Therapeutic Product 7.8.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Bayer HealthCare 7.9 Biogen 7.9.1 Company profile 7.9.2 Representative Lupus Therapeutic Product 7.9.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Biogen 7.10 Merck 7.10.1 Company profile 7.10.2 Representative Lupus Therapeutic Product 7.10.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Merck 7.11 Novartis 7.11.1 Company profile 7.11.2 Representative Lupus Therapeutic Product 7.11.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Novartis 7.12 Shire 7.12.1 Company profile 7.12.2 Representative Lupus Therapeutic Product 7.12.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Shire 7.13 Takeda Pharmaceuticals 7.13.1 Company profile 7.13.2 Representative Lupus Therapeutic Product 7.13.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Takeda Pharmaceuticals 7.14 Bristol-Myers Squibb 7.14.1 Company profile 7.14.2 Representative Lupus Therapeutic Product 7.14.3 Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Chapter 8 Upstream and Downstream Market Analysis of Lupus Therapeutic 8.1 Industry Chain of Lupus Therapeutic 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Lupus Therapeutic 9.1 Cost Structure Analysis of Lupus Therapeutic 9.2 Raw Materials Cost Analysis of Lupus Therapeutic 9.3 Labor Cost Analysis of Lupus Therapeutic 9.4 Manufacturing Expenses Analysis of Lupus Therapeutic Chapter 10 Marketing Status Analysis of Lupus Therapeutic 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Anti-inflammatory Drugs Table Advantage and Disadvantage of Corticosteroids Table Advantage and Disadvantage of Immunosuppressant Drugs Table Advantage and Disadvantage of Antimalarial Drugs Table Advantage and Disadvantage of Others Table Consumption Volume of Lupus Therapeutic in United States by Regions 2013-2017 Table Revenue of Lupus Therapeutic in United States by Regions 2013-2017 Table Consumption Volume of Lupus Therapeutic in United States by Regions 2018-2023 Table Revenue of Lupus Therapeutic in United States by Regions 2018-2023 Table Consumption Volume of Lupus Therapeutic in United States by Types 2013-2017 Table Revenue of Lupus Therapeutic in United States by Types 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in New England 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in The Midwest 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in The West 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in The South 2013-2017 Table Consumption Volume of Lupus Therapeutic by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Lupus Therapeutic in United States by Types 2018-2023 Table Revenue Forecast of Lupus Therapeutic in United States by Types 2018-2023 Table Demand Volume of Lupus Therapeutic in United States by Downstream Industry 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in New England 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in The West 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in The South 2013-2017 Table Demand Volume of Lupus Therapeutic by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Lupus Therapeutic in United States by Downstream Industry 2018-2023 Table Sales Volume of Lupus Therapeutic in United States by Major Players 2013-2017 Table Revenue of Lupus Therapeutic in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Lupus Therapeutic Major Players Table Employees and Revenue Level of Lupus Therapeutic Major Players Table Representative Lupus Therapeutic Product One of F.Hoffmann-La Roche Table Representative Lupus Therapeutic Product Two of F.Hoffmann-La Roche Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche 2013-2017 Table Representative Lupus Therapeutic Product One of GlaxoSmithKline Table Representative Lupus Therapeutic Product Two of GlaxoSmithKline Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017 Table Representative Lupus Therapeutic Product One of Medlmmune Table Representative Lupus Therapeutic Product Two of Medlmmune Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Medlmmune 2013-2017 Table Representative Lupus Therapeutic Product One of Pfizer Table Representative Lupus Therapeutic Product Two of Pfizer Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Lupus Therapeutic Product One of ADMA Biologics Table Representative Lupus Therapeutic Product Two of ADMA Biologics Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of ADMA Biologics 2013-2017 Table Representative Lupus Therapeutic Product One of Amgen Table Representative Lupus Therapeutic Product Two of Amgen Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Amgen 2013-2017 Table Representative Lupus Therapeutic Product One of Anthera Pharmaceuticals Table Representative Lupus Therapeutic Product Two of Anthera Pharmaceuticals Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Anthera Pharmaceuticals 2013-2017 Table Representative Lupus Therapeutic Product One of Bayer HealthCare Table Representative Lupus Therapeutic Product Two of Bayer HealthCare Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Bayer HealthCare 2013-2017 Table Representative Lupus Therapeutic Product One of Biogen Table Representative Lupus Therapeutic Product Two of Biogen Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Biogen 2013-2017 Table Representative Lupus Therapeutic Product One of Merck Table Representative Lupus Therapeutic Product Two of Merck Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Lupus Therapeutic Product One of Novartis Table Representative Lupus Therapeutic Product Two of Novartis Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Lupus Therapeutic Product One of Shire Table Representative Lupus Therapeutic Product Two of Shire Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Shire 2013-2017 Table Representative Lupus Therapeutic Product One of Takeda Pharmaceuticals Table Representative Lupus Therapeutic Product Two of Takeda Pharmaceuticals Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Takeda Pharmaceuticals 2013-2017 Table Representative Lupus Therapeutic Product One of Bristol-Myers Squibb Table Representative Lupus Therapeutic Product Two of Bristol-Myers Squibb Table Lupus Therapeutic Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb 2013-2017